Back
Supernus Pharmaceuticals Quote, Financials, Valuation and Earnings
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
31
SUPN
Supernus Pharmaceuticals
Last Price:
31.91
Seasonality Move:
-3.54%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn MoreSupernus Pharmaceuticals Price Quote
$31.91
-0.12 (-0.37%)
(Updated: October 2, 2024 at 11:20 AM ET)
Supernus Pharmaceuticals Key Stats
Sell
31
Supernus Pharmaceuticals (SUPN)
is a Sell
Day range:
$30.83 - $32.32
52-week range:
$21.99 - $35.44
Dividend yield:
0%
P/E ratio:
1,601.50
P/S ratio:
2.81
P/B ratio:
1.84%
Volume:
353.9K
Avg. volume:
362.5K
1-year change:
16.18%
Market cap:
$1.8B
Revenue:
$607.5M
EPS:
$0.09
How Much Does Supernus Pharmaceuticals Make?
-
How Much Are Supernus Pharmaceuticals's Sales Annually?
SUPN Revenues are $607.5M -
How Much Profit Does Supernus Pharmaceuticals's Make A Year?
SUPN net income is $1.3M
Is Supernus Pharmaceuticals Growing As A Company?
-
What Is Supernus Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.24% -
What Is Supernus Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Supernus Pharmaceuticals Stock Price Performance
-
Did Supernus Pharmaceuticals Stock Go Up Last Month?
Supernus Pharmaceuticals share price went down by -8.9% last month -
Did SUPN's Share Price Rise Over The Last Year?
SUPN share price rose by 16.18% over the past 1 year
What Is Supernus Pharmaceuticals 52-Week High & Low?
-
What Is Supernus Pharmaceuticals’s 52-Week High Share Price?
Supernus Pharmaceuticals has traded as high as $35.44 over the past 52 weeks -
What Is Supernus Pharmaceuticals’s 52-Week Low Share Price?
Supernus Pharmaceuticals has traded as low as $21.99 over the past 52 weeks
Supernus Pharmaceuticals Price To Free Cash Flow
-
Is Supernus Pharmaceuticals Stock Overvalued?
Supernus Pharmaceuticals is trading at a price to free cash flow ratio of 11.47 -
Is Supernus Pharmaceuticals Stock Undervalued?
Supernus Pharmaceuticals EV to Free Cash Flow ratio is 9.18 -
What Is Supernus Pharmaceuticals’s Price Earnings Growth Ratio?
SUPN PEG ratio is 0.00 -
Is Supernus Pharmaceuticals Trading At A Premium To Earnings?
Supernus Pharmaceuticals EV to EBIT ratio is 37.89
Is It Risky To Buy Supernus Pharmaceuticals?
-
How Much Debt Does Supernus Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Supernus Pharmaceuticals Have?
Cash and short term investments quarterly total is $347.2M -
What Is Supernus Pharmaceuticals’s Book Value Per Share?
Book value per share is 17.39
Is Supernus Pharmaceuticals Cash Flow Positive?
-
What Is SUPN Cash Flow From Operations?
Cash flow from operations (TTM) is $154.9M -
What Is Supernus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.1M -
What Is Supernus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$131.6M
Supernus Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SUPN return on invested capital is 0.57% -
What Is Supernus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 0.41% -
What Is SUPN Return On Equity?
ROE is a measure of profitability and is 0.57%
Supernus Pharmaceuticals Earnings Date & Stock Price
-
What Is Supernus Pharmaceuticals's Stock Price Today?
A single share of SUPN can be purchased today for 32.03 -
What Is Supernus Pharmaceuticals’s Stock Symbol?
Supernus Pharmaceuticals trades on the nasdaq under the ticker symbol: SUPN -
When Is Supernus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Supernus Pharmaceuticals is scheduled on November 8, 2024 -
When Is SUPN's next ex-dividend date?
Supernus Pharmaceuticals's next ex-dividend date is May 7, 2020 -
How To Buy Supernus Pharmaceuticals Stock?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Supernus Pharmaceuticals Competitors
-
Who Are Supernus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Supernus Pharmaceuticals or are related in some way:
Supernus Pharmaceuticals Dividend Yield
-
What Is SUPN Dividend Yield?
Supernus Pharmaceuticals’s dividend yield currently is 0% -
What Is Supernus Pharmaceuticals’s Payout Ratio?
Supernus Pharmaceuticals’s payout ratio is 0% -
When Did Supernus Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 2, 2024 -
What Is Supernus Pharmaceuticals’s Dividend Per Share?
Supernus Pharmaceuticals pays a dividend of $0.00 per share
Supernus Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 71.44% |
| Revenue: | 24.17% | 13.08% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 39.25 |
| Upside from Last Price: | 22.54% |